Dr. Gelfand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
S50801 Infectious Disease Associates
Boston, MA 02114Phone+1 617-726-1796Fax+1 617-726-2894
Education & Training
- Johns Hopkins UniversityChief Residency, Internal Medicine, 1976 - 1977
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1974 - 1976
- Johns Hopkins UniversityResidency, Internal Medicine, 1971 - 1973
- Tufts University School of MedicineClass of 1971
- University of PennsylvaniaA.B., Honors, 1967
Certifications & Licensure
- MA State Medical License 1977 - 2025
- MD State Medical License 1973 - 1982
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Fellow AAAS, 2007
- Edward M. Kennedy Award CIMIT, 2005
- New England Business and Technology Award 2004
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsDiminished In Vitro Production of Interleukin-1 and Tumor Necrosis Factor-α during Acute Visceral Leishmaniasis and Recovery after TherapyJohn L. Ho, Roberto Badaró, Anna Schwartz, Charles A. Dinarello, Jeffery A. Gelfand
The Journal of Infectious Diseases. 1992-06-01 - 29 citationsLaser vaccine adjuvants: History, progress, and potentialSatoshi Kashiwagi, Timothy Brauns, Jeffrey A. Gelfand, Mark C. Poznansky
Human Vaccines & Immunotherapeutics. 2014-04-29 - 296 citationsAnticytokine Strategies in the Treatment of the Systemic Inflammatory Response SyndromeCharles A. Dinarello, Jeffrey A. Gelfand, Sheldon M. Wolff
JAMA. 1993-04-14
Journal Articles
- Brief Exposure of Skin to near-Infrared Laser Modulates Mast Cell Function and Augments the Immune ResponseJeffrey Gelfand, Mark C Poznansky, The Journal of Immunology
- A Novel Laser Vaccine Adjuvant Increases the Motility of Antigen Presenting CellsChen X, Kim P, Farinelli W, Doukas A, Gelfand JA, Anderson RR and Wu MX, PLoS One, 10/1/2010
- Increased Dense Erythrocytes in Flame-burned PatientsSaavedra A, Norton K, Burke J, Warth J, Gelfand J, Clin Hemorheol Microcirc, 1/1/2013
- Join now to see all
Press Mentions
- Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with the Vaccine &Amp; Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer VaccineJune 9th, 2020
- Hoth Update on HaloVax Partnership Vaccine to Fight COVID-19 with Sponsored Research Agreement with the Vaccine and Immunotherapy Center (VIC) of the Massachusetts General Hospital (MGH)April 2nd, 2020
- HaloVax Announces Agreement with Hoth TherapeuticsMarch 29th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: